Status: current, Defined. Date: 31-Aug 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 979785981000036116 | Gliclazide MR (Apo) (gliclazide 30 mg) modified release tablet, 100 tablets, bottle (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 979785991000036119 | Gliclazide MR (Apo) 30 mg modified release tablet, 100, bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Gliclazide MR (Apo) 30 mg modified release tablet, 100, bottle | has TPUU | Gliclazide MR (Apo) 30 mg modified release tablet | true | Inferred relationship | Some | 1 | |
| Gliclazide MR (Apo) 30 mg modified release tablet, 100, bottle | has TP | Gliclazide MR (Apo) | true | Inferred relationship | Some | ||
| Gliclazide MR (Apo) 30 mg modified release tablet, 100, bottle | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Gliclazide MR (Apo) 30 mg modified release tablet, 100, bottle | Is a | Gliclazide MR (Apo) 30 mg modified release tablet, 100 | true | Inferred relationship | Some | ||
| Gliclazide MR (Apo) 30 mg modified release tablet, 100, bottle | has container type | bottle | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Australian dialect reference set
Description inactivation indicator reference set
Containered trade product pack reference set
FHIR